Strategic Investment Advisors Abbott Laboratories Transaction History

Strategic Investment Advisors

  • $909 Million
  • Q3 2024

A detailed history of Strategic Investment Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Strategic Investment Advisors holds 7,347 shares of ABT stock, worth $843,141. This represents 0.09% of its overall portfolio holdings.

Number of Shares
7,347
Previous 7,842 6.31%
Holding current value
$843,141
Previous $814,000 2.83%
% of portfolio
0.09%
Previous 0.1%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
SELL
$100.07 - $118.13 $49,534 - $58,474
-495 Reduced 6.31%
7,347 $837,000
Q2 2024

Jul 22, 2024
BUY
$100.73 - $112.44 $31,830 - $35,531
316 Added 4.2%
7,842 $814,000
Q1 2024

Apr 22, 2024
BUY
$109.52 - $120.96 $29,241 - $32,296
267 Added 3.68%
7,526 $855,000
Q4 2023

Jan 10, 2024
SELL
$90.19 - $110.4 $59,074 - $72,312
-655 Reduced 8.28%
7,259 $798,000
Q3 2023

Oct 24, 2023
SELL
$95.53 - $114.62 $16,526 - $19,829
-173 Reduced 2.14%
7,914 $766,000
Q2 2023

Aug 14, 2023
BUY
$100.78 - $112.29 $94,632 - $105,440
939 Added 13.14%
8,087 $881,000
Q1 2023

Apr 27, 2023
SELL
$96.86 - $114.01 $638,501 - $751,553
-6,592 Reduced 47.98%
7,148 $723,000
Q4 2022

Jan 19, 2023
BUY
$95.06 - $111.52 $240,311 - $281,922
2,528 Added 22.55%
13,740 $0
Q3 2022

Oct 27, 2022
SELL
$96.76 - $112.03 $5,805 - $6,721
-60 Reduced 0.53%
11,212 $1.09 Million
Q2 2022

Aug 15, 2022
SELL
$102.07 - $123.37 $10,921 - $13,200
-107 Reduced 0.94%
11,272 $1.23 Million
Q1 2022

Apr 28, 2022
SELL
$114.02 - $139.04 $28,390 - $34,620
-249 Reduced 2.14%
11,379 $1.35 Million
Q4 2021

Jan 26, 2022
BUY
$115.53 - $141.46 $6,585 - $8,063
57 Added 0.49%
11,628 $1.64 Million
Q3 2021

Oct 19, 2021
BUY
$116.66 - $129.06 $87,844 - $97,182
753 Added 6.96%
11,571 $1.37 Million
Q2 2021

Jul 22, 2021
BUY
$105.79 - $124.53 $315,148 - $370,974
2,979 Added 38.0%
10,818 $1.25 Million
Q1 2021

Apr 14, 2021
BUY
$108.84 - $128.23 $76,623 - $90,273
704 Added 9.87%
7,839 $939,000
Q4 2020

Jan 13, 2021
BUY
$105.0 - $114.42 $108,255 - $117,967
1,031 Added 16.89%
7,135 $781,000
Q3 2020

Oct 14, 2020
BUY
$91.64 - $111.29 $79,910 - $97,044
872 Added 16.67%
6,104 $664,000
Q2 2020

Aug 04, 2020
BUY
$76.57 - $98.0 $27,794 - $35,574
363 Added 7.46%
5,232 $478,000
Q1 2020

Apr 13, 2020
BUY
$62.82 - $91.86 $99,820 - $145,965
1,589 Added 48.45%
4,869 $384,000
Q4 2019

Jan 23, 2020
SELL
$78.51 - $87.4 $157 - $174
-2 Reduced 0.06%
3,280 $285,000
Q3 2019

Oct 25, 2019
BUY
$81.84 - $88.74 $1,636 - $1,774
20 Added 0.61%
3,282 $275,000
Q2 2019

Jul 23, 2019
BUY
$72.88 - $85.0 $237,734 - $277,270
3,262 New
3,262 $274,000

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Strategic Investment Advisors Portfolio

Follow Strategic Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

News

Stay updated on Strategic Investment Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email